RIBON
Live / Registered — Registered (as of 20 Dec 2022)
What this means for you
Registered since 20 Dec 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88638873
- Registration number
- 6931419
- Mark type
- Stylized text
- Filed
- 02 Oct 2019
- Published for opposition
- 18 Feb 2020
- Registered
- 20 Dec 2022
- Attorney of record
- John V. Hobgood, Esquire
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the diagnosis and treatment of oncologic diseases
Owner
- Ribon Therapeutics, Inc., Cambridge, MA, US
- Ribon Therapeutics, Inc., Cambridge, MA, US
- Ribon Therapeutics, Inc., Lexington, MA, US
Prosecution history
- 20 Dec 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Dec 2022 — REGISTERED-PRINCIPAL REGISTER
- 12 Nov 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Nov 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Nov 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Nov 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Nov 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Nov 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Nov 2022 — NON-FINAL ACTION E-MAILED
- 08 Nov 2022 — SU - NON-FINAL ACTION - WRITTEN
- 07 Nov 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 31 Oct 2022 — USE AMENDMENT FILED
- 31 Oct 2022 — TEAS STATEMENT OF USE RECEIVED
- 20 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Oct 2022 — SOU EXTENSION 5 GRANTED